Skip to content

Syndax Pharmaceuticals SNDX Other Country — Income Taxes Paid Net

Similar metrics at other companies

Enliven Therapeutics logo
ELVNOther States — Income Taxes Paid Net
$0-100%
Ultragenyx Pharmaceutical logo
RAREOther — Income Tax Paid Foreign After Refund Received
$500K
Schlumberger
 logo
SLBOther Country — Income Taxes Paid Net
$215.75M+7.3%
Kaiser Aluminum logo
KALUOther State — Income Taxes Paid Net
$75K-40.0%
First Advantage Corporation logo
FAOther Countries — Income Tax Paid Foreign After Refund Received
$500.75K+47.7%
Cinemark Holdings logo
CNKOther — Income Tax Paid Foreign After Refund Received
$1.03M

Other financials

Income statement

See full
Revenue$64.9M+224%
Operating income-$34.2M+59.2%
Net income-$42.7M+49.7%
EPS (diluted)-$0.48+51.0%

Balance sheet

See full
Cash & equivalents$130.9M-15.0%
Total debt$350.5M+4.2%
Total equity$41.6M-80.6%
Total assets$472.7M-26.2%

Cash flow

See full
Operating cash flow-$50.3M+47.1%
CapEx$46.8K
Free cash flow-$80.8M-17.6%

Valuation

See full
Market cap$1.74B+95.0%
Enterprise value$1.96B+84.0%
P/S-12.4×

Profitability

See full
Operating margin-102.8%-47.8pp
Net margin-111.9%-51.5pp
FCF margin-187.2%-85.4pp

Returns & leverage

See full
Return on equity-189.5%-8,509pp
Debt / equity8.4×+6.9×
Current ratio5.5×-0.3×

Where this comes from

Reported directly by Syndax Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxesPaidNet.

The official record: Syndax Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Syndax Pharmaceuticals's other country — income taxes paid net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Syndax Pharmaceuticals's other country — income taxes paid net?
Syndax Pharmaceuticals (SNDX) reported other country — income taxes paid net of $2.5 in Q4 2025.
What does other country — income taxes paid net mean?
This metric represents the net cash outflows for income taxes attributable to the company's operations within geographic regions classified as 'Other Country'. It reflects the actual tax payments made to foreign tax authorities after accounting for any refunds or credits received. Monitoring this figure helps investors assess the tax burden and regulatory compliance costs associated with international clinical development and business activities outside of primary markets.